The ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic Telangiectasia
about
The ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic Telangiectasia
description
clinical trial
@en
klinisch onderzoek
@nl
name
The ELLIPSE Study: A Phase-1 S ...... ary Hemorrhagic Telangiectasia
@en
type
label
The ELLIPSE Study: A Phase-1 S ...... ary Hemorrhagic Telangiectasia
@en
prefLabel
The ELLIPSE Study: A Phase-1 S ...... ary Hemorrhagic Telangiectasia
@en
P1476
The ELLIPSE Study: A Phase-1 S ...... ry Hemorrhagic Telangiectasia.
@en
P1813
ELLIPSE
@en
P3098
NCT01507480
P4844
P580
2011-10-01T00:00:00Z
P582
2012-12-01T00:00:00Z